These results suggest that GDF15 inhibitors may help to relieve the inhibitory effect of SPP1 + TAMs on CD8 + T cells, thereby improving the killing ability of CD8 + T cells and inhibiting liver metastasis of gastric cancer. The gene discussed is CD8A; the disease is gastric cancer.